Elisabeth Stichmann advises domestic and international clients across the whole range of corporate law including regulatory advice for the market entry to Austria.

She focuses on M&A, corporate commercial, strategic advice of shareholders in listed and private companies, global corporate restructuring of company groups including post-M&A integration and pre-acquisition structuring, as well as on setting up, structuring and operating private foundations.

Acting as DLA Piper’s Life Sciences country lead for Austria she has in-depth knowledge of the life sciences sector and regularly advises clients on industry-specific legal matters.

Due to her global orientation, her membership to the international corporate reorganizations core team and her strong link to the US, she is regularly coordinating cross-border teams on the implementation of various transactions irrespective of whether there is an angle to Austria. Another core aspect of her advisory work includes supporting corporations on aspects of corporate management and compliance.

Furthermore, Elisabeth regularly advises the representative organs of private foundations on operational questions and professional liability aspects and represents such clients in court. Elisabeth also held positions in the management boards of several Austrian private foundations.